Table 3 Summarises the diagnostic criteria of the different disease categories.
| Disease category | Diagnostic criteria | References |
|---|---|---|
| RCD I | Villous atrophy persisted or recurred despite strict adherence to a gluten‐free diet. (assessed by a dietician and negative tTG antibodies) | 2–4 8 19 |
| At least partial villous atrophy (Marsh IIIA) according to the modified Marsh criteria | ||
| Excluding other causes of villous atrophy | ||
| When ⩽10% aberrant T cells in intestinal biopsy | ||
| IEL phenotype is normal with the expression of surface CD3, CD8 and TCR | ||
| RCD II | The same as RCD I, in addition to the presence of ⩾20% aberrant T cells in intestinal biopsy | 2–4 8 19 |
| The IELs have normal morphology, but exhibit an aberrant phenotype (normal expression of CD103 and CD7, downregulation of surface CD3 to intracytoplasmic CD3, and the lack of surface T‐cell markers: CD4, CD8 and TCRs) | ||
| EATL has been confidently excluded | ||
| Secondary EATL | WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues | 45 46 |
| The patient is already known to have RCD | ||
| Primary (de novo) EATL | WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues | 45 46 |
| No previous history of complicated coeliac disease | ||
| Evidence of Marsh IIIA‐C in non‐involved mucosa |
IEL, intraepithelial T lymphocyte; RCD, refractory coeliac disease; TCR, T‐cell receptor; tTG, tissue transglutaminase; WHO, World Health Organization.